Current investigations into retatruptide peptide highlight notable possibility for managing obesity get more info and non-insulin dependent diabetes. The molecule, a dual stimulator of GLP-1 receptor and GIP receptor, looks to offer improved weight reduction and glycemic regulation in contrast to existing medications. Further patient studies are re